Literature DB >> 9771677

Cold preserved nerve allografts: changes in basement membrane, viability, immunogenicity, and regeneration.

P J Evans1, S E Mackinnon, A D Levi, J A Wade, D A Hunter, Y Nakao, R Midha.   

Abstract

Rat sciatic nerve graft segments were harvested and pretreated by either placement in the University of Wisconsin Cold Storage Solution at 5 degrees C and storage from 1 to 26 weeks, or repeatedly freezing (-40 degrees C) and thawing (20 degrees C). Following pretreatment, grafts were transplanted as either syngeneic or allogeneic nerve grafts. Storage and freeze-thawing did not affect the Schwann cell basal lamina or laminin distribution of the peripheral nerve. Graft cell viability decreased with increasing time of storage, with some viable cells detectable even after 3 weeks of storage. Freeze-thawed grafts were not viable. Increasing time of storage led to decreasing immune response and graft rejection, but improved regeneration. Freeze-thawed and 26-week stored allografts were nonimmunogenic and rejection was not seen, but regeneration was delayed compared to autografts. Graft storage may become a useful adjunct to clinical nerve allografting to permit elective scheduling of surgery, provide greater time for preoperative tissue testing, and possibly blunt the immune response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771677     DOI: 10.1002/(sici)1097-4598(199811)21:11<1507::aid-mus21>3.0.co;2-w

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  22 in total

1.  Experience with nerve allograft transplantation.

Authors:  Ida K Fox; Susan E Mackinnon
Journal:  Semin Plast Surg       Date:  2007-11       Impact factor: 2.314

2.  Chondroitinase treatment increases the effective length of acellular nerve grafts.

Authors:  Debbie Neubauer; James B Graham; David Muir
Journal:  Exp Neurol       Date:  2007-06-23       Impact factor: 5.330

3.  The impact of motor and sensory nerve architecture on nerve regeneration.

Authors:  Arash Moradzadeh; Gregory H Borschel; Janina P Luciano; Elizabeth L Whitlock; Ayato Hayashi; Daniel A Hunter; Susan E Mackinnon
Journal:  Exp Neurol       Date:  2008-04-23       Impact factor: 5.330

4.  The effects of cold preservation and subimmunosuppressive doses of FK506 on axonal regeneration in murine peripheral nerve isografts.

Authors:  Terence M Myckatyn; Daniel A Hunter; Susan E Mackinnon
Journal:  Can J Plast Surg       Date:  2003

5.  Localized delivery of immunosuppressive regulatory T cells to peripheral nerve allografts promotes regeneration of branched segmental defects.

Authors:  Kelly C Santos Roballo; Subash Dhungana; Zhongliang Jiang; John Oakey; Jared S Bushman
Journal:  Biomaterials       Date:  2019-04-17       Impact factor: 12.479

6.  Acellular nerve allografts in peripheral nerve regeneration: a comparative study.

Authors:  Amy M Moore; Matthew MacEwan; Katherine B Santosa; Kristofer E Chenard; Wilson Z Ray; Daniel A Hunter; Susan E Mackinnon; Philip J Johnson
Journal:  Muscle Nerve       Date:  2011-06-09       Impact factor: 3.217

7.  Tissue engineered constructs for peripheral nerve surgery.

Authors:  P J Johnson; M D Wood; A M Moore; S E Mackinnon
Journal:  Eur Surg       Date:  2013-06       Impact factor: 0.953

8.  The role of T helper cell differentiation in promoting nerve allograft survival with costimulation blockade.

Authors:  Wilson Z Ray; Rahul Kasukurthi; Esther M Papp; Amy M Moore; Andrew Yee; Daniel A Hunter; Nancy L Solowski; Thalachallour Mohanakumar; Susan E Mackinnon; Thomas H Tung
Journal:  J Neurosurg       Date:  2010-02       Impact factor: 5.115

9.  Effect of cold nerve allograft preservation on antigen presentation and rejection.

Authors:  Wilson Z Ray; Santosh S Kale; Rahul Kasukurthi; Esther M Papp; Philip J Johnson; Katherine B Santosa; Ying Yan; Daniel A Hunter; Susan E Mackinnon; Thomas H Tung
Journal:  J Neurosurg       Date:  2010-06-18       Impact factor: 5.115

10.  Axonal regeneration into acellular nerve grafts is enhanced by degradation of chondroitin sulfate proteoglycan.

Authors:  C A Krekoski; D Neubauer; J Zuo; D Muir
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.